Correction to: Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders
- PDF / 381,539 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 61 Downloads / 182 Views
CORRECTION
Correction to: Current Status of Antisense Oligonucleotide‑Based Therapy in Neuromuscular Disorders Flavien Bizot1 · Adeline Vulin1,2 · Aurélie Goyenvalle1,3
© Springer Nature Switzerland AG 2020
Correction to: Drugs https://doi.org/10.1007/s40265-020-01363-3
The second author, which currently reads as: Adeline Vulin-Chaffiol Should read as: Adeline Vulin The original article has been updated.
The original article can be found online at https://doi.org/10.1007/ s40265-020-01363-3. * Aurélie Goyenvalle [email protected] 1
Université Paris-Saclay, UVSQ, Inserm, END-ICAP, 78000 Versailles, France
2
SQY Therapeutics, Université de Versailles St-Quentin, Montigny le Bretonneux, France
3
LIA BAHN, Centre scientifique de Monaco, Monaco, Monaco
Vol.:(0123456789)
Data Loading...
